You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

Claims for Patent: 7,393,537


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,393,537
Title:Botulinum toxin for treatment of obsessive compulsive finger biting disorder
Abstract: Methods for treating obsessions and compulsions by local administration of a Clostridial toxin. The obsessions or compulsions can be eye poking, body rocking, finger biting, counting, checking and related disorders treated by low dose, intramuscular administration of a botulinum toxin.
Inventor(s): Ackerman; Alan H. (Greeley, CO)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:10/423,380
Patent Claims:1. A method of treating obsessive compulsive finger biting disorder in a human patient having the disorder, comprising local administration of a therapeutically effective amount of a botulinum toxin, by intramuscular, subcutaneous, subdermal or transdermal route, to an arm or a forearm of said patient, thereby treating said obsessive compulsive finger biting disorder in said patient.

2. The method of claim 1, wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, L, F and G.

3. The method of claim 1, wherein the botulinum toxin is type A botulinum toxin.

4. The method of claim 1, wherein the obsessive compulsive finger biting disorder is treated for between about one month and about five years.

5. The method of claim 1, wherein the local administration is by intramuscular injection.

6. A method of treating obsessive compulsive finger biting disorder in a human patient having the disorder, comprising local administration of a therapeutically effective amount of botulinum toxin type A to a hand muscle of said patient, thereby treating said obsessive compulsive finger biting disorder for between about one month and about five years.

7. A method of treating a human patient with obsessive compulsive finger biting disorder comprising local administration to base of each finger of the patient a therapeutically effective amount of botulinum toxin type A, thereby treating said obsessive compulsive finger biting disorder in said patient.

8. A method of treating a human patient with obsessive compulsive finger biting disorder comprising local administration to base of each finger of the patient a therapeutically effective amount of botulinum toxin type B, thereby treating said obsessive compulsive finger biting disorder in said patient.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.